More than four out of five deaths (83.9%) were in white patients. That group is more likely to be exposed to risk factors ...

Despite a record expansion in medical seats in 2025 which lifted the total above 1.3 lakhs, NEET applicants still outnumber ...

Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...

Findings from a new study have revealed that vitamin D influences depression risk by affecting early neurodevelopmental ...

Findings point to importance of RSV vaccination in older patients with systemic autoimmune rheumatic diseases.

A new study published in Frontiers in Medicine revealed a strong link between autoimmune diseases (AID) and the prevalence of ...

In MIBC patients, ctDNA-guided, adjuvant atezolizumab treatment is associated with significant survival improvements over placebo.

Check NEET UG 2026 dates for application form release, exam day, answer key, and result announcement. Know the complete month ...

Experts continue to debate whether the health status benefits are real and enough to justify doing the procedures for severe ...

Regorafenib and nivolumab showed noninferior survival compared to chemotherapy in advanced gastric or GEJ cancer, with higher response and disease control rates. The study involved patients with prior ...

The National Medical Commission (NMC) has revised the NEET UG 2025–26 seat matrix by raising the total number of MBBS seats ...

Managing perioperative opioid risks, improving detection of peripheral artery disease and surgical management of hard-to-treat gastrointestinal cancers, were among the topics UCSF surgeons, clinicians ...